The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis
Open accessAbstract
Recent studies suggested that JAK2V617F mutation is frequent in patients with splanchnic vein thrombosis (SVT) but not in patients with other venous thromboembolic events (VTE). However, whether screening for the JAK2V617F mutation in VTE patients is justified remains unclear. Therefore, we performed a systematic review to assess the frequency of JAK2 mutation in VTE patients and the role of JAK2V617F mutation in the diagnosis of myeloproliferative neoplasms. MEDLINE and EMBASE databases were searched. Two reviewers independently performed study selection and extracted study characteristics. Pooled odds ratios of case-control studies and weighted mean proportion of the prevalence of JAK2V617F mutation of uncontrolled series were calculated. Twenty-four studies involving 3123 patients were included. Mean prevalence of JAK2 mutation was 32.7% (95% confidence interval, 25.5%-35.9%) in SVT patients. JAK2 mutation was associated with increased risk of SVT (odds ratio, 53.98; 95% confidence interval, 13.10-222.45). Mean prevalence of JAK2 mutation in other VTE patients was low (range, 0.88%-2.57%). Presence of JAK2V617F mutation in SVT patients was associated with a subsequent diagnosis of myeloproliferative neoplasm in many patients. JAK2 mutation is strongly associated with SVT, and routine screening of JAK2 mutation appears to be indicated in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A meta-analysis reported a JAK2 mutationprevalenceof32.7%(95%CI25.5 e 35.9%)inpatients with AMVT compared with approximately 1% in patients with VTEinothersites, and found a strong association between JAK2 mutation and MVT (OR 53.9, 95% CI 13.1 e 222.5). 214”
In the citing paper
“A meta-analysis reported a JAK2 mutationprevalenceof32.7%(95%CI25.5 e 35.9%)inpatients with AMVT compared with approximately 1% in patients with VTEinothersites, and found a strong association between JAK2 mutation and MVT (OR 53.9, 95% CI 13.1 e 222.5). 214”
In the citing paper
“The JAK2 mutation is diagnostic of myeloproliferative diseases and appears to be linked to the development of AMVT.”
In the citing paper
“Moreover, 52% (95% CI 38 e 67%) of patients with MVT and JAK2 mutation were diagnosed with a myeloproliferative disease during follow up, with MVT being the first manifestation of the underlying condition. 214”
In the citing paper
“AMVT is a common first clinical manifestation in patients with newly diagnosed myeloproliferative diseases such as polycythemia vera or essential thrombocytosis.”
In the citing paper
“A meta-analysis reported a JAK2 mutationprevalenceof32.7%(95%CI25.5 e 35.9%)inpatients with AMVT compared with approximately 1% in patients with VTEinothersites, and found a strong association between JAK2 mutation and MVT (OR 53.9, 95% CI 13.1 e 222.5). 214”
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Tefferi, A., Thiele, J., Orazi, A., Kvasnicka, H., Barbui, T., Hanson, C., Barosi, G., Verstovsek, S., Birgegard, G., Mesa, R., et al. (2007) · Blood · doi:10.1182/blood-2007-04-083501 · Cited by 919
Campbell, P. J., Scott, L. M., Buck, G. A. N., Wheatley, K., East, C. L., Marsden, J. T., Duffy, A. M., Boyd, E. M., Bench, A. J., Scott, M. A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67785-9 · Cited by 651
Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years
Policitemia, G. I. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00003 · Cited by 507
Cited by
Sorted by citations
Epidemiology of venous thromboembolism
Heit, J. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.83 · Cited by 1,277
The epidemiology of venous thromboembolism
Heit, J. A., Spencer, F. A., & White, R. H. R. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1311-6 · Cited by 1,142
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658
Therapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 413
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
Smalberg, J. H., Arends, L. R., Valla, D. C., Kiladjian, J., Janssen, H. L. A., & Leebeek, F. W. G. (2012) · Blood · doi:10.1182/blood-2011-09-376517 · Cited by 374
Nguyen, G. C., Bernstein, C. N., Bitton, A., Chan, A. K. C., Griffiths, A. M., Leontiadis, G. I., Geerts, W. H., Bressler, B. L., Butzner, J. D., Carrier, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.042 · Cited by 354
Streiff, M. B., Holmstrom, B., Angelini, D. E., Ashrani, A. A., Buckner, T. W., Diep, R. T., Fertrin, K. Y., Fogerty, A. E., Gallastegui, N., Gangaraju, R., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.0046 · Cited by 200
Prevention and Treatment of Venous Thromboembolism
Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R. D., Myers, K. A., Samama, M. M., Fletcher, J., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840 · Cited by 187
Riva, N., Donadini, M. P., & Ageno, W. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0563 · Cited by 146
Self-citationSplanchnic vein thrombosis: clinical presentation, risk factors and treatment
Stefano, V. D., & Martinelli, I. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0413-6 · Cited by 127
Splanchnic Vein Thrombosis: Current Perspectives
Valeriani, E., Riva, N., Nisio, M. D., & Ageno, W. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s197732 · Cited by 120
Self-citationCancer associated thrombosis: risk factors and outcomes
Eichinger, S. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30092-5 · Cited by 110
Koelemay, M. J., Geelkerken, R. H., Kärkkäinen, J., Leone, N., Antoniou, G. A., de Bruin, J. L., Gombert, A., Gottsätter, A., Iborra, E., Ronchey, S., et al. (2025) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2025.06.010 · Cited by 123
Bench, A. J., White, H., Foroni, L., Godfrey, A. L., Gerrard, G., Akiki, S. J., Awan, A., Carter, I. W. J., Goday‐Fernández, A., Langabeer, S. E., et al. (2012) · British Journal of Haematology · doi:10.1111/bjh.12075 · Cited by 94
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH
Delluc, A., Antic, D. A., Lecumberri, R., Ay, C., Meyer, G., & Carrier, M. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13791 · Cited by 94
Haemostasis and thrombosis in liver disease
Roberts, L. N., Patel, R., & Arya, R. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08021.x · Cited by 90
How I treat splanchnic vein thrombosis
Ageno, W., Dentali, F., & Squizzato, A. (2014) · Blood · doi:10.1182/blood-2014-07-551515 · Cited by 88
Self-citationBetti, S., Rossi, E., Stefano, V. D., & Qi, X. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-04-0326 · Cited by 88
Qi, X., Stefano, V. D., Wang, J., Bai, M., Yang, Z., Han, G., & Fan, D. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12085 · Cited by 83
How I treat essential thrombocythemia
Rumi, E., & Cazzola, M. (2016) · Blood · doi:10.1182/blood-2016-05-643346 · Cited by 83
Thrombotic risk factors in Chinese Budd-Chiari syndrome patients
He, C., Yin, Z., Niu, J., Bai, M., Yang, Z., Wu, K., Fan, D., Qi, X., Wu, K., Ren, W., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0784 · Cited by 80
Sant’Antonio, E., Guglielmelli, P., Pieri, L., Primignani, M., Randi, M. L., Santarossa, C., Rumi, E., Cervantes, F., Delaini, F., Carobbio, A., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25677 · Cited by 81
Splanchnic vein thrombosis in myeloproliferative neoplasms
Sekhar, M., McVinnie, K., & Burroughs, A. K. (2013) · British Journal of Haematology · doi:10.1111/bjh.12461 · Cited by 78
The JAK2 V617F mutation in patients with cerebral venous thrombosis
Passamonti, S. M., Biguzzi, E., Cazzola, M., Franchi, F., Gianniello, F., Bucciarelli, P., Pietra, D., Mannucci, P. M., & Martinelli, I. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04719.x · Cited by 75
Qi, X., Yang, Z., Bai, M., Shi, X., Han, G., & Fan, D. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04627.x · Cited by 73
Multidetector CT Features of Mesenteric Vein Thrombosis
Durán, R., Denys, A. L., Letovanec, I., Meuli, R. A., & Schmidt, S. (2012) · Radiographics · doi:10.1148/rg.325115100 · Cited by 71
Portal Vein Thrombosis: State-of-the-Art Review
Boccatonda, A., Gentilini, S., Zanata, E., Simion, C., Serra, C., Simioni, P., Piscaglia, F., Campello, E., & Ageno, W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051517 · Cited by 74
Self-citationHow, J., Zhou, A. W., & Oh, S. T. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716680333 · Cited by 73
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment
Riva, N., Donadini, M. P., Dentali, F., Squizzato, A., & Ageno, W. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.259 · Cited by 67
Self-citationSmalberg, J. H., Kruip, M. J. H. A., Janssen, H. L. A., Rijken, D. C., Leebeek, F. W. G., & de Maat, M. P. M. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213371 · Cited by 67
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
Finazzi, G., Stefano, V. D., & Barbui, T. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0100-9 · Cited by 63
Current management strategies for polycythemia vera and essential thrombocythemia
Guglielmelli, P., & Vannucchi, A. M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100714 · Cited by 62
Cerebral venous thrombosis and myeloproliferative neoplasms: Results from two large databases
Dentali, F., Ageno, W., Rumi, E., Casetti, I. C., Poli, D., Scoditti, U., Maffioli, M., Minno, M. N. D. D., Caramazza, D., Pietra, D., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.040 · Cited by 61
Self-citationVannucchi, A. M. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0319-3 · Cited by 57
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
Accurso, V., Santoro, M., Mancuso, S., Napolitano, M., Carlisi, M., Mattana, M., Russo, C., Stefano, A. D., Sirocchi, D., & Siragusa, S. M. (2020) · Clinical Medicine Insights Blood Disorders · doi:10.1177/2634853520978210 · Cited by 56
Liu, P. M. F., Ferreira, A. R., Fagundes, E. D. T., Liu, S. M., Roquete, M. L. V., & Penna, F. J. (2012) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032012000100012 · Cited by 53
Portal vein thrombosis: When to treat and how?
Sharma, A., Zhu, D., & Henry, Z. H. (2015) · Vascular Medicine · doi:10.1177/1358863x15611224 · Cited by 53
JAK2 Mutation-Related Disease and Thrombosis
Guglielmelli, P., & Vannucchi, A. M. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1343890 · Cited by 51
Rare thromboses of cerebral, splanchnic and upper-extremity veins
Stefano, V. D., & Martinelli, I. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-12-0873 · Cited by 49
Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
Magaz, M., Álvarez‐Larrán, A., Colomer, D., López‐Guerra, M., García‐Criado, Á., Gabriel Mezzano, P., Belmonte, E., Olivas, P., Soy, G., Cervantes, F., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.045 · Cited by 47
Appelmann, I., Kreher, S., Parmentier, S. B., Wolf, H., Bisping, G., Kirschner, M., Bergmann, F., Schilling, K., Brümmendorf, T. H., Petrides, P. E., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2621-2 · Cited by 45
Elliott, M. A., Pardanani, A. D., Lasho, T. L., Schwager, S. M., & Tefferi, A. (2010) · Haematologica · doi:10.3324/haematol.2010.025064 · Cited by 43
Handa, P. K., Crowther, M. A., & Douketis, J. D. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612473515 · Cited by 41
Self-citationJAK2V617F mutation in patients with thrombosis: to screen or not to screen?
Xavier, S. G., Gadelha, T., Rezende, S. M., Zalcberg, I. R., & Spector, N. (2010) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2010.01275.x · Cited by 40
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
Shetty, S., & Ghosh, K. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.09.019 · Cited by 39
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era
Falchi, L., Kantarjian, H. M., & Verstovšek, S. (2017) · Leukemia · doi:10.1038/leu.2017.150 · Cited by 39
Abdominal thromboses of splanchnic, renal and ovarian veins
Stefano, V. D., & Martinelli, I. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.07.002 · Cited by 38
Clinical Management of Acute Portal/Mesenteric Vein Thrombosis
Lang, S. A., Loss, M., Wohlgemuth, W. A., & Schlitt, H. J. (2014) · Visceral Medicine · doi:10.1159/000369896 · Cited by 36
Acquired thrombotic risk factors in the critical care setting
Ortel, T. L. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c9ccc8 · Cited by 35
Colaizzo, D., Amitrano, L., Guardascione, M. A., Tiscia, G. L., D’Andrea, G., Longo, V., Grandone, E., & Margaglione, M. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.014 · Cited by 35
Zarrouk, M., Salim, S., Elf, J., Gottsäter, A., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.11.002 · Cited by 35
Yönal, İ., Pınarbaşı, B., Hindilerden, F., Hançer, V. S., Nalçacı, M., Kaymakoğlu, S., & Küçükkaya, R. D. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0738-2 · Cited by 33
Qi, X., Yang, Z., Stefano, V. D., & Fan, D. (2014) · Hepatology Research · doi:10.1111/hepr.12348 · Cited by 33
Stefano, V. D., Rossi, E., Zà, T., Ciminello, A., Betti, S., Luzzi, C., Leone, G. G. M., & Chiusolo, P. (2011) · American Journal of Hematology · doi:10.1002/ajh.22024 · Cited by 33
Uses and Abuses of JAK2 and MPL Mutation Tests in Myeloproliferative Neoplasms
Tefferi, A., Noël, P., & Hanson, C. A. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.05.007 · Cited by 32
Barbui, T., Stefano, V. D., Falanga, A., Finazzi, G., Martinelli, I., Rodeghiero, F., Vannucchi, A. M., & Barosi, G. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0225-5 · Cited by 31
State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review
Gavriilidis, P., Marangoni, G., Ahmad, J., & Azoulay, D. (2022) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4724 · Cited by 32
Liu, P. M. F., Ferreira, A. R., Fagundes, E. D. T., Xavier, S. G., Ribeiro, D. D., Fernandes, A. P., Borges, K. B. G., Liu, S. M., de Melo, M. D. C. B., Roquete, M. L. V., et al. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318261814d · Cited by 32
Barosi, G., Vannucchi, A. M., Stefano, V. D., Pane, F., Passamonti, F., Rambaldi, A., Saglio, G. N., Barbui, T., & Tura, S. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.09.008 · Cited by 32
How, J., Trinkaus, K. M., & Oh, S. T. (2017) · British Journal of Haematology · doi:10.1111/bjh.14958 · Cited by 29
CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA
Stefano, V. D., Zà, T., Ciminello, A., Betti, L., & Rossi, E. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.063 · Cited by 27
Screening for Occult Cancer in Patients with Venous Thromboembolism
D’Astous, J., & Carrier, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082389 · Cited by 27
Advances in the Management of Cancer-Associated Thrombosis
Dhami, S. P. S., Patmore, S., & O’Sullivan, J. M. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1722863 · Cited by 27
De, T., Prabhakar, P., Nagaraja, D., & Christopher, R. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.012 · Cited by 27
Naymagon, L., Tremblay, D. A., Zubizarreta, N. J., Moshier, E. L., Schiano, T. D., & Mascarenhas, J. O. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02052-4 · Cited by 27
Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis
Roques, M., Park, J., Minello, A., Bastie, J. N., & Girodon, F. (2014) · British Journal of Haematology · doi:10.1111/bjh.13235 · Cited by 27
Portal vein thrombosis: A concise review (Review)
Costache, R. S., Dragomirică, A. S., Dumitraș, E., Jinga, M., Căruntu, A., Popescu, A., & Costache, D. O. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10191 · Cited by 26
Should We Screen for Janus Kinase 2 V617F Mutation in Cerebral Venous Thrombosis?
Lamy, M., Palazzo, P., Agius, P., Chomel, J., Ciron, J., Berthomet, A., Cantagrel, P., Prigent, J., Ingrand, P., Puyade, M., et al. (2017) · Cerebrovascular Diseases · doi:10.1159/000471891 · Cited by 26
Sood, S. L. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832ea31b · Cited by 25
JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
Vannucchi, A. M. (2010) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-009-0038-x · Cited by 25
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
Liu, A., Naymagon, L., & Tremblay, D. A. (2022) · Cancers · doi:10.3390/cancers15010011 · Cited by 24
Ball, S., Thein, K. Z., Maiti, A., & NUGENT, K. M. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1623-4 · Cited by 25
Liver in haematological disorders
Pieri, G., Theocharidou, E., & Burroughs, A. K. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.06.012 · Cited by 21
Gianelli, U., Iurlo, A., Cattaneo, D., Bossi, A., Cortinovis, I., Augello, C., Moro, A., Savi, F., Castelli, R., Brambilla, C., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.03.009 · Cited by 20
Colaizzo, D., Tiscia, G. L., Bafunno, V., Amitrano, L., Vergura, P., Lupone, M. R., Grandone, E., Guardascione, M. A., & Margaglione, M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.024 · Cited by 20
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology
Chia, Y. C., Jusoh, S. A. M., Ramli, M., Woon, P. Y., Johan, M. F., Hassan, R., & Islam, M. A. (2023) · Diagnostics · doi:10.3390/diagnostics13010163 · Cited by 21
Li, S., Zhang, P.-J., Sun, G., & Lu, Z. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2134-9 · Cited by 19
Colaizzo, D., Tiscia, G. L., Bafunno, V., Amitrano, L., Vergura, P., Grandone, E., Guardascione, M. A., & Margaglione, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03691.x · Cited by 19
Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detection
Lefèvre, A., Soyer, P. A., Vahedi, K., Guerrache, Y., Bellucci, S., Gault, V., & Boudiaf, M. (2011) · Clinical Imaging · doi:10.1016/j.clinimag.2010.03.006 · Cited by 18
Ahluwalia, J., Naseem, S., Sachdeva, M. U. S., Bose, P. L., Bose, S. K., Kumar, N., Thapa, B. R., Varma, N., & Chawla, Y. K. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12265 · Cited by 18
Splanchnic vein thrombosis: new risk factors and management
Donadini, M. P., Dentali, F., & Ageno, W. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70025-7 · Cited by 18
Self-citationDevelopments in diagnosis and treatment of essential thrombocythemia
Mora, B., & Passamonti, F. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1585239 · Cited by 19
Donadini, M. P., & Ageno, W. (2011) · Seminars in Hematology · doi:10.1053/j.seminhematol.2011.08.005 · Cited by 17
Self-citationIanotto, J., Chauveau, A., Mottier, D., Ugo, V., Berthou, C., Lippert, É., & Delluc, A. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2853-1 · Cited by 16
Hematological Issues in Critically Ill Patients with Cancer
Carlson, K.-S., & DeSancho, M. T. (2009) · Critical Care Clinics · doi:10.1016/j.ccc.2009.09.006 · Cited by 16
Zaman, S. U., Wiebe, S., Bernal, W. E., Wendon, J. A., Czuprynska, J., & Auzinger, G. M. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000632 · Cited by 16
Imaging features of myeloproliferative neoplasms
Murphy, I., Mitchell, E. L., Rásó‐Barnett, L., Godfrey, A. L., & Godfrey, E. M. (2017) · Clinical Radiology · doi:10.1016/j.crad.2017.05.014 · Cited by 16
Colaizzo, D., Amitrano, L., Guardascione, M. A., Favuzzi, G., Tiscia, G. L., D’Andrea, G., Santacroce, R., Grandone, E., & Margaglione, M. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-12-1055 · Cited by 15
Levraut, M., Legros, L., Drappier, C., Béné, M. C., Queyrel, V., Raynaud, S., & Martis, N. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02100-z · Cited by 14
Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?
Zerjavic, K., Zagradišnik, B., Herodež, Š. S., Lokar, L., Kraševac, M. G., & Vokač, N. K. (2010) · Acta Haematologica · doi:10.1159/000314645 · Cited by 15
Pescia, C., Lopez, G., Cattaneo, D., Bucelli, C., Gianelli, U., & Iurlo, A. (2023) · Leukemia Research · doi:10.1016/j.leukres.2023.107420 · Cited by 14
Jones, C., Levy, Y. M., & Tong, A. W. (2014) · BMJ Case Reports · doi:10.1136/bcr-2014-205663 · Cited by 14
Shedding Light on the Pathogenesis of Splanchnic Vein Thrombosis
Camerlo, S., Ligato, J., Rosati, G., Carrà, G., Russo, I., Gobbi, M. D., & Morotti, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032262 · Cited by 12
Bourrienne, M., Duchez, V. L. C., Faille, D., Farkh, C., Nomenjanahary, M. S., Gay, J., Loyau, S., Journé, C., Dupont, S., Ollivier, V., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011692 · Cited by 13
Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature
Găman, M., Cozma, M.-A., Manan, M. R., Srichawla, B. S., Dhali, A., Ali, S., Nahian, A., Elton, A. C., Kutikuppala, L. V. S., Suteja, R. C., et al. (2023) · World Journal of Clinical Oncology · doi:10.5306/wjco.v14.i3.99 · Cited by 13
New Therapeutic Approaches in Polycythemia Vera
Falchi, L., Newberry, K. J., & Verstovšek, S. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.013 · Cited by 13
Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
Lauw, M. N., Bus, E. W. N., Palthe, A. F. V. W., Coppens, M., Homburg, C., Middeldorp, S., van der Schoot, C. E., Koene, H. R., & Biemond, B. J. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1233-0 · Cited by 13
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Janjetovic, S., Beckmann, L., Holstein, K., Rolling, C. C., Thiele, B., Schafhausen, P., Schön, G., Bokemeyer, C., Länger, F. P., & Voigtlaender, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.11.027 · Cited by 12
Yoo, E., JANG, J. ‐., PARK, K. ‐., Gwak, G., Kim, H., KIM, S. ‐., & Kim, D. (2011) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2011.01308.x · Cited by 12
Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M. M., Fletcher, J. M., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840m · Cited by 11
Metadata
- Authors
- Dentali, F., Squizzato, A., Brivio, L., Appio, L., Campiotti, L., Crowther, M., Grandi, A. M., & Ageno, W.
- Affiliations
- University of Insubria (IT)
- McMaster University (CA)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2009-05-28
- Volume
- 113
- Issue
- 22
- Pages
- 5617-5623
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2000782581
- Cited by
- 176
- References
- 60
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 12 · 2013: 13 · 2012: 18
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- JAK2 V617F mutation, myeloproliferative neoplasms, venous thromboembolism, splanchnic vein thrombosis, mutation detection, early diagnosis, prevalence
- MeSH terms
- Algorithms, Female, Gene Frequency, Humans, Male, Myeloproliferative Disorders, Neoplasms, Phenylalanine, Philadelphia Chromosome, Biomarkers, Tumor, Valine, Case-Control Studies, Point Mutation, Amino Acid Substitution, Janus Kinase 2, Venous Thromboembolism, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
